In light of litifilimab recently receiving FDA Breakthrough Therapy Designation for CLE, we spoke with experts to discuss ...

The FDA grants Fast Track designation to nipocalimab for systemic lupus erythematosus following positive results from the phase 2b JASMINE trial.

Phase 3 trial data show that obinutuzumab significantly reduces disease activity in very active extrarenal lupus.

Johnson & Johnson's nipocalimab has been granted U.S. Food and Drug Administration Fast Track designation as a potential ...

Lupus is more common in Black people, and symptoms can be different too. Here's what to look out for and how to treat it.

Treatment with loncastuximab tesirine-lpyl was associated with the development of dermatologic adverse events (dAEs) in 20% of patients with relapsed or refractory diffuse large B‑cell lymphoma; these ...

Shontia Matlock was 19 and pregnant when she was diagnosed with lupus, a chronic autoimmune disease that can cause fatigue, joint pain, and skin changes. It wasn’t a total shock. “Everybody in my ...

This explainer details common lupus warning signs and why early recognition matters for clinical assessment. It outlines lupus symptoms such as photosensitivity associated with rashes, low-grade fever ...

Lupus is a complex autoimmune disease that can affect any part of the body, and its symptoms often appear gradually, come and go, or look like those of other conditions. If you think you might have ...

"TMVII is a specific type of fungus that is part of a larger family that causes the usually benign but irksome conditions such as ringworm, jock itch and athlete's foot," Dr. Hayden Andrews, an ...